Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Technology-Driven Precision Medicine Company Variantyx Secures $41.5M in Funding
Variantyx, a technology-driven precision medicine company providing advanced genomic testing for the rare genetic disorders, […]
Biktarvy ® Demonstrates High Efficacy and Durable Viral Suppression at Five Years, in Treatment-Naïve Adults
Gilead Sciences, Inc. (Nasdaq: GILD) today announced the presentation of cumulative 5-year results from two […]
MayaMD & LG Electronics Offer New AI Healthcare at Home Program Via Smart TV
MayaMD, one of LG NOVA’s Proto Challenge first winners, will offer its AI health assistant […]
Anil Jain, M.D., FACP, Joins Innovaccer Leadership Team as Chief Innovation Officer
Innovaccer Inc., the Health Cloud company, is pleased to welcome Anil Jain, M.D., FACP, to its […]
Aromatase Inhibitors Cut Breast Cancer Recurrence in Younger Patients
Drugs called aromatase inhibitors reduce the risk of breast cancer returning by compared with oestrogen […]
Vinehealth Named the Most Innovative Cancer Patient Support Tool in the Global Health & Pharma News Technology Awards 2021
Vinehealth has been named as the Most Innovative Cancer Patient Support Tool in the Global […]
GenesisCare Enrolls First Patients to SpaceOAR Vue™ Hydrogel Global Clinical Trial
GenesisCare—one of the leading oncology providers in the United States, Australia, Spain and the United […]
NHS Vaccination Lead Comments On Boosters Preventing An Estimated 105,000 Hospitalisations
Commenting on analysis published by the UKHSA today estimating that over 105,000 hospitalisations in people […]
New Two-year Data for Roche’s Vabysmo and Susvimo Reinforce Potential to Maintain Vision with Fewer Treatments for People with Two Leading Causes of Vision Loss
Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that new two-year data from its phase […]
Merck KGaA, Darmstadt, Germany, Enters into Option Agreement with Quris on its BioAI Platform for Clinical Safety Prediction
Quris, an artificial intelligence (AI) innovator disrupting the pharmaceutical arena, today announced it has signed […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more